Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$483M Buy
3,323,725
+1,390,058
+72% +$192M 0.05% 255
2026
Q2
$248M Sell
1,933,667
-1,887,560
-49% -$221M 0.03% 460
2026
Q1
$460M Sell
3,821,227
-3,000,104
-44% -$346M 0.07% 197
2025
Q4
$718M Buy
6,821,331
+5,853,277
+605% +$549M 0.11% 121
2025
Q3
$81.2M Buy
+968,054
New +$79.7M 0.01% 995
2025
Q2
– Sell
-2,048,739
Closed -$163M – 14120
2025
Q1
$184M Sell
2,048,739
-3,232,971
-61% -$302M 0.03% 398
2024
Q4
$525M Sell
5,281,710
-1,759,979
-25% -$181M 0.09% 135
2024
Q3
$800M Sell
7,041,689
-1,200,378
-15% -$143M 0.15% 74
2024
Q2
$1.02B Buy
8,242,067
+666,847
+9% +$85.9M 0.21% 59
2024
Q1
$1,000M Buy
7,575,220
+1,257,049
+20% +$155M 0.19% 61
2023
Q4
$689M Sell
6,318,171
-358,936
-5% -$37.3M 0.14% 71
2023
Q3
$687M Buy
6,677,107
+4,837,236
+263% +$521M 0.15% 66
2023
Q2
$212M Buy
1,839,871
+1,068,727
+139% +$121M 0.04% 303
2023
Q1
$82M Sell
771,144
-1,715,524
-69% -$185M 0.02% 730
2022
Q4
$276M Sell
2,486,668
-900,548
-27% -$92.1M 0.06% 226
2022
Q3
$292M Buy
3,387,216
+1,231,726
+57% +$110M 0.07% 192
2022
Q2
$197M Sell
2,155,490
-1,233,115
-36% -$109M 0.05% 285
2022
Q1
$278M Buy
3,388,605
+1,171,399
+53% +$92.4M 0.06% 232
2021
Q4
$170M Sell
2,217,206
-871,326
-28% -$69.4M 0.03% 412
2021
Q3
$232M Buy
3,088,532
+138,422
+5% +$10.5M 0.05% 296
2021
Q2
$229M Sell
2,950,110
-1,431,650
-33% -$106M 0.05% 276
2021
Q1
$338M Sell
4,381,760
-559,774
-11% -$43.3M 0.08% 152
2020
Q4
$404M Buy
4,941,534
+2,833,384
+134% +$227M 0.11% 113
2020
Q3
$175M Buy
2,108,150
+776,626
+58% +$63.8M 0.05% 238
2020
Q2
$103M Sell
1,331,524
-102,236
-7% -$8.07M 0.04% 391
2020
Q1
$110M Buy
1,433,760
+496,742
+53% +$40.9M 0.05% 305
2019
Q4
$85.2M Sell
937,018
-1,707,170
-65% -$147M 0.04% 471
2019
Q3
$223M Buy
2,644,188
+1,950,861
+281% +$164M 0.11% 131
2019
Q2
$58.1M Sell
693,327
-577,166
-45% -$46.3M 0.03% 652
2019
Q1
$106M Sell
1,270,493
-563,408
-31% -$44.2M 0.05% 344
2018
Q4
$140M Sell
1,833,901
-3,331,026
-64% -$246M 0.08% 219
2018
Q3
$366M Buy
5,164,927
+1,926,113
+59% +$129M 0.16% 70
2018
Q2
$197M Sell
3,238,814
-2,825,198
-47% -$167M 0.1% 156
2018
Q1
$330M Sell
6,064,012
-2,364,413
-28% -$134M 0.18% 60
2017
Q4
$474M Buy
8,428,425
+7,792,358
+1,225% +$453M 0.29% 36
2017
Q3
$40.7M Sell
636,067
-1,873,786
-75% -$119M 0.03% 651
2017
Q2
$161M Buy
2,509,853
+2,103,989
+518% +$134M 0.14% 114
2017
Q1
$25.8M Buy
405,864
+227,070
+127% +$14.4M 0.02% 800
2016
Q4
$10.5M Sell
178,794
-3,036,917
-94% -$186M 0.01% 1314
2016
Q3
$201M Buy
+3,215,711
New +$197M 0.2% 57
2016
Q2
– Sell
-219,984
Closed -$12.3M – 7351
2016
Q1
$11.6M Sell
219,984
-262,078
-54% -$13.5M 0.01% 1091
2015
Q4
$25.5M Buy
482,062
+412,734
+595% +$21.8M 0.03% 709
2015
Q3
$3.42M Sell
69,328
-1,173,696
-94% -$65.3M ﹤0.01% 2384
2015
Q2
$70.8M Buy
1,243,024
+335,459
+37% +$19.7M 0.06% 356
2015
Q1
$52.2M Sell
907,565
-199,556
-18% -$11.8M 0.05% 465
2014
Q4
$62.9M Sell
1,107,121
-987,991
-47% -$57.7M 0.06% 351
2014
Q3
$124M Buy
2,095,112
+1,737,374
+486% +$102M 0.13% 134
2014
Q2
$20.7M Sell
357,738
-1,490,786
-81% -$85.2M 0.02% 797
2014
Q1
$105M Buy
1,848,524
+1,761,020
+2,013% +$95.6M 0.12% 159
2013
Q4
$4.38M Sell
87,504
-1,975,695
-96% -$94.6M 0.01% 1792
2013
Q3
$98.2M Buy
2,063,199
+2,052,959
+20,048% +$98.2M 0.15% 119
2013
Q2
$476K Hold
10,240
– – ﹤0.01% 3884

Other funds holding MRK

Ken Griffin's MRK Position: Q3 2026 in Review

Ken Griffin increased its Merck (MRK) stake by 72% in Q3 2026, buying an estimated $192M and bringing the position to 3,323,725 shares worth $483M. The position accounts for 0.05% of the portfolio, ranked #255.

Ken Griffin first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.02B in Q2 2024. 3,977 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Ken Griffin held 3,323,725 shares of Merck worth $483M as of Q3 2026.
  • Ken Griffin bought 1,390,058 Merck shares in Q3 2026, an estimated $192M.
  • Merck made up 0.05% of Ken Griffin's portfolio in Q3 2026, its #255 holding.
  • Ken Griffin first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Ken Griffin's Merck position peaked at $1.02B in Q2 2024.
  • 3,977 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.